USFDA concludes audit at contract manufacturing facility of Jubilant Pharmova’s step down arm

18 Jun 2024 Evaluate

United States Food and Drug Administration (USFDA) has concluded audit at Jubilant Pharmova’s wholly-owned subsidiary -- Jubilant HollisterStier’s subsidiary -- Jubilant HollisterStier General Partnership’s (JHSGP) contract manufacturing facility located in Montreal, Canada. The USFDA has issued 15 observations pursuant to the completion of audit. JHSGP will submit an action plan on the observations.

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.


Jubilant Pharmova Share Price

1076.40 7.20 (0.67%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×